New route to treating Alzheimer’s Dementia
Boyds has been working with Australian-based biotech company, Actinogen Medical, to develop a novel approach to the treatment of Alzheimer’s disease. Rather than following the traditional treatment paths, it is taking a new route. This month the first of 174 patients on an international trial will begin taking a drug to lessen the level of […]
